KospicyKorean filings in English
Filings / Samsung Biologics

Issuance Results — Share Issue or Equity-linked Bonds — Voluntary

Samsung Biologics · 유상증자또는주식관련사채등의발행결과(자율공시)

OtherKOSPI · 207940 Filed 2026-11-17Korean original on DART

English form view 35% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Results of Paid-in Capital Increase or Equity-Linked Bond Issuance (Voluntary Disclosure)

1. Type of SecuritiesRegistered Common Shares
2. Issuance MethodRights offering to shareholders
3. Issuance DetailsShares to Be Issued (shares)2,270,000
Planned Issuance Amount (KRW)2,664,980,000,000
Initial Board Resolution Date for Issuance2026-08-28
Actual Shares Issued (shares)2,270,000
Actual Issuance Amount (KRW)2,664,980,000,000
Payment Date2026-11-17
4. Other Material Matters Relevant to Investment Decisions1. 당사의 2026-08-28 이사회 결의에 의한 유상증자(주주배정 후 실권주 일반공모)는 상기 내용과 같이 납입이 완료되었습니다. 2. 향후 진행일정

- 신주 추가상장 예정일 : 2026-11-30 |
| ※ Related Disclosures | 2026-11-05 유상증자결정 2026-11-05 증권신고서(지분증권) 2026-11-05 투자설명서 2026-11-05 유상증자 신주발행가액(안내공시) 2026-11-11 유상증자 또는 주식관련사채 등의 청약결과(자율공시) 2026-11-16 유상증자 또는 주식관련사채 등의 청약결과(자율공시) |